Cancer Focus Fund invests $4.5M in ImmunoGenesis human trials for cancer therapy
The investment continues the fund’s commitments to clinical-stage companies performing their first human trials.
Building "Bridges" Across the Bayou City!
The investment continues the fund’s commitments to clinical-stage companies performing their first human trials.